Prophylactic G-CSF was not allowed during Cycle 1 in the PROSELICA and TROPIC studies but was permitted in the CUP/EAP/CAPRISTANA studies; this may, in part, explain the lower rates of neutropenia observed in these studies [11,13,14,15]. Here, CSF3 is linked to Decreased total neutrophil count.